Page last updated: 2024-10-25

citalopram and Hyperlipemia

citalopram has been researched along with Hyperlipemia in 2 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glitho, S1
Boukari, L1
Mekinian, A1
Fain, O1
Beyenburg, S1
Schönegger, K1

Other Studies

2 other studies available for citalopram and Hyperlipemia

ArticleYear
[Dermatomyositis].
    La Revue du praticien, 2013, Volume: 63, Issue:5

    Topics: Aged; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Citalopram;

2013
Severe bradycardia in a stroke patient caused by a single low dose of escitalopram.
    European neurology, 2007, Volume: 57, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antidepressive Agents, Second-Generation

2007